- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02763124
Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions
October 11, 2019 updated by: Clayton Blehm, MD, Gainesville Eye Associates
To assess the effectiveness of the Verion-LenSx guided arcuate incision technique to reduce astigmatism in a pseudophakic population.
Study Overview
Detailed Description
The purpose of this study is to evaluate the effectiveness of corneal arcuate incisions when they are performed with a femtosecond laser system on subjects who have had previous cataract surgery.
The procedure to be used would not be different from that employed during cataract surgery, except that the only corneal incisions made would be the partial-depth arcuate incisions at the laser.
Study Type
Interventional
Enrollment (Actual)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Georgia
-
Gainesville, Georgia, United States, 30501
- Gainesville Eye Associates
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 40 or older
- Willing and able to provide informed consent for participation in the study.
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Verion-LenSx
The Verion-LenSx femtosecond laser system will be used to perform one or two corneal arcuate incisions.
|
The Verion-LenSx femtosecond laser system will be used to create one or two partial-depth corneal arcuate incisions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Uncorrected Monocular Distance Visual Acuity
Time Frame: 60 days (+/- 10 days) after laser treatment
|
Uncorrected monocular distance visual acuity, measured on a logMAR scale, (logarithm of the Minimum Angle of Resolution) which is a measure of visual acuity in which the smaller values indicate better visual acuity.
|
60 days (+/- 10 days) after laser treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Corneal Astigmatism
Time Frame: 60 days (+/- 10 days) after laser treatment
|
Vector change in the astigmatism measured on the cornea, in diopters
|
60 days (+/- 10 days) after laser treatment
|
|
Change in Refractive Cylinder
Time Frame: 60 days (+/- 10 days) after laser treatment
|
The vector change in refractive cylinder in diopters
|
60 days (+/- 10 days) after laser treatment
|
|
Spectacle Independence at Distance
Time Frame: 60 days (+/- 10 days) after laser treatment
|
Percentage of subjects that do not rely on spectacles for distance vision
|
60 days (+/- 10 days) after laser treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2016
Primary Completion (Actual)
October 1, 2016
Study Completion (Actual)
October 1, 2016
Study Registration Dates
First Submitted
May 3, 2016
First Submitted That Met QC Criteria
May 3, 2016
First Posted (Estimate)
May 5, 2016
Study Record Updates
Last Update Posted (Actual)
November 1, 2019
Last Update Submitted That Met QC Criteria
October 11, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CB-16-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Astigmatism
-
Bausch & Lomb IncorporatedNot yet recruiting
-
London Vision ClinicOptana GmbHActive, not recruitingCorneal AstigmatismUnited Kingdom
-
Eye Hospital Pristina KosovoActive, not recruiting
-
Yonsei UniversityUnknownMyopic AstigmatismKorea, Republic of
-
Abbott Medical OpticsCompletedRefractive AstigmatismAustria
-
Ohio State UniversityAlcon ResearchCompletedAstigmatism BilateralUnited States
-
Ohio State UniversityCompletedAstigmatism BilateralUnited States
-
CooperVision, Inc.Completed
-
Cairo UniversityUnknown
Clinical Trials on Verion-LenSx
-
LenSx Lasers Inc.Completed
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Second Affiliated Hospital, School of Medicine,...Enrolling by invitation
-
Democritus University of ThraceCompleted
-
Alcon LenSx, Inc.Completed
-
Alcon ResearchCompleted
-
Maastricht University Medical CenterCompleted
-
LenSx Lasers Inc.CompletedCataract | Corneal DiseaseUnited States
-
Alcon ResearchCompletedMyopia | HyperopiaUnited States